Evolent Health (EVH) Stock Price

Evolent Health Price

NYSE·CLOSED
3.09USD-0.09 (-2.87 %)
Market closed

Over the last 13 years Evolent Health grew revenue by 51.7% annually, reaching 1.88 B USD. For Evolent Health, the net margin of -28.5% is down versus -4.1% a few years ago. The consensus 12-month price target for Evolent Health is 8.67 USD, about 180.6% above where the stock trades today. Of 20 analysts, 18 rate the stock a buy — an overall Buy consensus. The stock trades about 42% above its 52-week low.

Evolent Health stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Evolent Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Evolent Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Evolent Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Evolent Health Stock Price History
DateEvolent Health Price
7/31/20263.09 USD
7/30/20263.18 USD
7/29/20263.48 USD
7/27/20264.04 USD
7/23/20264.64 USD
7/22/20265.57 USD
7/21/20265.85 USD
7/20/20265.93 USD
7/17/20265.81 USD
7/16/20265.67 USD
7/15/20265.87 USD
7/14/20266.19 USD
7/13/20265.97 USD
7/10/20265.88 USD
7/9/20265.63 USD
7/8/20265.45 USD
7/7/20265.48 USD
7/6/20265.76 USD
7/2/20265.71 USD
7/1/20265.74 USD
6/30/20265.42 USD
6/29/20265.77 USD
6/26/20265.51 USD
6/25/20265.03 USD
6/24/20265.03 USD
6/23/20264.80 USD
6/22/20264.41 USD
6/18/20264.39 USD
6/17/20264.82 USD
6/16/20264.78 USD
6/15/20264.76 USD
6/12/20264.72 USD
6/11/20264.58 USD
6/10/20264.64 USD
6/9/20264.72 USD
6/8/20264.66 USD
6/5/20264.22 USD
6/4/20264.38 USD
6/3/20263.78 USD
6/2/20263.96 USD
6/1/20264.17 USD
5/29/20263.95 USD
5/28/20263.90 USD
5/27/20263.72 USD
5/26/20263.83 USD
5/22/20263.95 USD
5/21/20263.84 USD
5/20/20263.86 USD
5/19/20263.89 USD
5/18/20263.90 USD
5/15/20263.96 USD
5/14/20264.10 USD
5/13/20264.13 USD
5/12/20264.16 USD
5/11/20263.96 USD
5/8/20264.18 USD
5/7/20264.27 USD
5/6/20263.83 USD
5/5/20263.91 USD
5/4/20263.99 USD
5/1/20263.75 USD
4/30/20263.75 USD
4/29/20263.79 USD
4/28/20263.62 USD
4/27/20263.47 USD
4/24/20263.13 USD
4/23/20263.01 USD
4/22/20263.10 USD
4/21/20263.15 USD
4/20/20262.93 USD
4/17/20262.84 USD
4/16/20262.99 USD
4/15/20262.88 USD
4/14/20262.51 USD
4/13/20262.53 USD
4/10/20262.33 USD
4/9/20262.44 USD
4/8/20262.56 USD
4/7/20262.54 USD
4/6/20262.31 USD
4/2/20262.25 USD
4/1/20262.22 USD
3/31/20262.28 USD
3/30/20262.17 USD
3/27/20262.21 USD
3/26/20262.38 USD
3/25/20262.27 USD
3/24/20262.25 USD
3/23/20262.49 USD
3/20/20262.58 USD
3/19/20262.74 USD
3/18/20262.67 USD
3/17/20262.83 USD
3/16/20263.02 USD
3/13/20262.99 USD
3/12/20263.06 USD
3/11/20263.02 USD
3/10/20263.07 USD
3/9/20263.04 USD
3/6/20263.17 USD
3/5/20263.40 USD
3/4/20263.55 USD
3/3/20263.51 USD
3/2/20263.58 USD
2/27/20263.25 USD
2/26/20263.32 USD
2/25/20263.14 USD
2/24/20262.56 USD
2/23/20262.77 USD
2/20/20262.79 USD
2/19/20262.77 USD
2/18/20262.78 USD
2/17/20262.72 USD
2/13/20262.79 USD
2/12/20262.64 USD
2/11/20262.67 USD
2/10/20262.73 USD
2/9/20262.73 USD
2/6/20262.85 USD
2/5/20262.89 USD
2/4/20263.06 USD
2/3/20263.09 USD
2/2/20263.26 USD
1/30/20263.21 USD
1/29/20263.24 USD
1/28/20263.23 USD
1/27/20263.40 USD
1/26/20263.71 USD
1/23/20263.94 USD
1/22/20263.84 USD
1/21/20263.80 USD
1/20/20263.94 USD
1/16/20263.77 USD
1/15/20263.94 USD
1/14/20263.90 USD
1/13/20264.01 USD
1/12/20264.15 USD
1/9/20264.17 USD
1/8/20264.16 USD
1/7/20264.15 USD
1/6/20264.02 USD
1/5/20263.95 USD
1/2/20263.89 USD
12/31/20254.00 USD
12/30/20254.05 USD
12/29/20254.07 USD
12/26/20254.12 USD
12/24/20254.13 USD
12/23/20254.16 USD
12/22/20254.02 USD
12/19/20253.99 USD
12/18/20253.97 USD
12/17/20254.04 USD
12/16/20254.07 USD
12/15/20254.12 USD
12/12/20254.12 USD
12/11/20253.94 USD
12/10/20253.88 USD
12/9/20253.94 USD
12/8/20253.93 USD
12/5/20253.94 USD
12/4/20254.01 USD
12/3/20253.91 USD
12/2/20253.88 USD
12/1/20254.00 USD
11/28/20254.20 USD
11/26/20254.20 USD
11/25/20254.31 USD
11/24/20254.27 USD
11/21/20254.14 USD
11/20/20253.69 USD
11/19/20253.54 USD
11/18/20254.00 USD
11/17/20253.87 USD
11/14/20254.18 USD
11/13/20254.16 USD
11/12/20254.45 USD
11/11/20255.04 USD
11/10/20254.95 USD
11/7/20254.96 USD
11/6/20256.00 USD
11/5/20256.35 USD
11/4/20256.49 USD
11/3/20256.72 USD
10/31/20256.67 USD
10/30/20256.60 USD
10/29/20257.08 USD
10/28/20257.41 USD
10/27/20257.64 USD
10/24/20257.81 USD
10/23/20257.50 USD
10/22/20258.08 USD
10/21/20258.18 USD
10/20/20257.76 USD
10/17/20257.53 USD
10/16/20257.80 USD
10/15/20257.84 USD
10/14/20257.71 USD
10/13/20257.68 USD
10/10/20257.94 USD
10/9/20258.17 USD
10/8/20258.05 USD
10/7/20258.12 USD
10/6/20258.25 USD
10/3/20258.23 USD
10/2/20257.89 USD
10/1/20258.03 USD
9/30/20258.46 USD
9/29/20258.77 USD
9/26/20258.95 USD
9/25/20258.92 USD
9/24/20259.61 USD
9/23/20258.39 USD
9/22/20258.59 USD
9/19/20258.38 USD
9/18/20258.74 USD
9/17/20258.54 USD
9/16/20258.64 USD
9/15/20258.62 USD
9/12/20259.02 USD
9/11/20259.31 USD
9/10/20259.19 USD
9/9/20259.99 USD
9/8/20259.67 USD
9/5/20259.61 USD
9/4/20259.49 USD
9/3/20259.58 USD
9/2/20259.61 USD
8/29/20259.65 USD
8/28/20259.64 USD
8/27/20259.62 USD
8/26/20259.27 USD
8/25/20259.70 USD
8/22/20259.60 USD
8/21/20258.77 USD
8/20/20258.96 USD
8/19/20259.00 USD
8/18/20259.02 USD
8/15/20259.30 USD
8/14/20258.82 USD
8/13/20258.97 USD
8/12/20258.80 USD
8/11/20259.22 USD
8/8/20259.00 USD
8/7/20259.69 USD
8/6/20259.41 USD
8/5/20259.50 USD
8/4/20259.77 USD
Access this data via the Eulerpool API
Get Free API Key

Evolent Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
1.96 B USD
-71.21 M USD
-113.04 M USD
Jan 1, 2024
2.55 B USD
-38.31 M USD
-61.62 M USD
Jan 1, 2025
1.88 B USD
-477.17 M USD
-534.51 M USD
Jan 1, 2026 (e)
2.50 B USD
-192.25 M USD
20.17 M USD
Jan 1, 2027 (e)
2.94 B USD
-226.04 M USD
39.33 M USD
Jan 1, 2028 (e)
3.29 B USD
-252.48 M USD
51.20 M USD
Jan 1, 2029 (e)
3.72 B USD
-285.45 M USD
78.12 M USD
Jan 1, 2030 (e)
4.10 B USD
-314.58 M USD
92.63 M USD

Evolent Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 3, 2026, 1:06 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
0.100.250.430.630.690.920.911.351.962.551.882.502.943.293.724.10
-4.00164.5870.8744.479.5734.50-1.8449.0645.1930.11-26.5533.4217.5811.6913.0510.23
40.6338.9838.0247.6925.3324.6827.5623.3723.4314.3715.1415.1415.1415.1415.1415.14
39.0099.00165.00299.00174.00228.00250.00316.00460.00367.00284.00378.92445.53497.61562.55620.08
-42.00-237.00-74.00-52.00-319.00-302.00-42.003.00-71.00-38.00-477.00-192.00-226.00-252.00-285.00-314.00
-43.75-93.31-17.05-8.29-46.43-32.68-4.630.22-3.62-1.49-25.43-7.67-7.68-7.67-7.67-7.67
332.00-159.00-60.00-52.00-301.00-334.00-37.00-19.00-113.00-61.00-534.0020.0039.0051.0078.0092.00
-1,428.00-147.89-62.26-13.33478.8510.96-88.92-48.65494.74-46.02775.41-103.7595.0030.7752.9417.95
41.4852.1874.6978.7283.9484.2988.3399.80113.59115.03114.21114.21114.21114.21114.21114.21
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Evolent Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Evolent Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Evolent Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Evolent Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Evolent Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Evolent Health stock margins

The Evolent Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Evolent Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Evolent Health.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
27.58 %
-4.67 %
-4.14 %
Jan 1, 2022
23.42 %
0.27 %
-1.42 %
Jan 1, 2023
23.45 %
-3.63 %
-5.76 %
Jan 1, 2024
14.38 %
-1.50 %
-2.41 %
Jan 1, 2025
15.14 %
-25.43 %
-28.49 %
Jan 1, 2026 (e)
15.14 %
-7.68 %
0.81 %
Jan 1, 2027 (e)
15.14 %
-7.68 %
1.34 %
Jan 1, 2028 (e)
15.14 %
-7.68 %
1.56 %

Evolent Health Stock Revenue, EBIT, Earnings per Share

The Evolent Health earnings per share therefore indicates how much revenue Evolent Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
10.28 USD
-0.48 USD
-0.43 USD
Jan 1, 2022
13.55 USD
0.04 USD
-0.19 USD
Jan 1, 2023
17.29 USD
-0.63 USD
-1.00 USD
Jan 1, 2024
22.21 USD
-0.33 USD
-0.54 USD
Jan 1, 2025
16.43 USD
-4.18 USD
-4.68 USD
Jan 1, 2026 (e)
22.43 USD
-1.68 USD
0.18 USD
Jan 1, 2027 (e)
26.37 USD
-1.98 USD
0.35 USD
Jan 1, 2028 (e)
29.46 USD
-2.21 USD
0.46 USD

Evolent Health business model & stock analysis

Evolent Health Inc was founded in 2011 and is a healthcare services company based in Arlington, VA USA. The company was founded by a group of CEOs and executives to revolutionize the healthcare system and reduce healthcare costs in the US. Evolent, a wordplay on "evolution" and "diligent," is committed to improving healthcare services through innovative ideas and technologies. Over the years, Evolent Health's business model has evolved and expanded to meet the needs of a wide range of healthcare organizations and their patients. The company works with healthcare organizations such as hospitals, medical centers, health plans, and physicians to provide effective and affordable healthcare solutions. Evolent Health offers various services tailored to the needs of different healthcare organizations. One of their core competencies is the development and implementation of population health management programs. These programs aim to improve patient health while reducing costs. The company also offers technology platforms that healthcare organizations can use to manage data, improve treatment outcomes, and facilitate communication between doctors and patients. Another important aspect of Evolent Health is the care of Medicare and Medicaid patients. The company works with health plans to provide better healthcare services to these underserved populations. Evolent Health also offers specialized services, such as the treatment of patients with chronic conditions like diabetes or cardiovascular diseases. In recent years, Evolent Health has also expanded its portfolio through acquisitions and partnerships. In 2018, two acquisitions were completed, namely Valence Health and New Century Health. These acquisitions have strengthened Evolent Health's position in the field of population health management programs and specialized services for cancer patients. Another innovative product of Evolent Health is the Virtual Health Center. This program offers virtual consultations and treatments for patients who cannot make in-person visits to doctors due to distance or busy lifestyles. The program utilizes state-of-the-art telemedicine technology to provide patients with high-quality medical care while allowing them to stay comfortably at home. Evolent Health has an impressive track record in improving patient outcomes and reducing healthcare costs. In 2020, the company received the highest rating in the "Population Health Management" category of the Healthcare Informatics 100 Rankings. The company serves nearly 3 million patients in the US and operates in over 30 states. Overall, the company has the potential to change the healthcare system in the US and beyond through its vision, innovation, and commitment to high-quality healthcare services. Evolent's focus on improving healthcare delivery and reducing costs has the potential to be a role model for the entire industry.

Evolent Health SWOT Analysis

Strengths

Evolent Health Inc possesses several notable strengths that contribute to its success and market position. These strengths include:

  • Strong strategic partnerships: Evolent Health has formed strategic alliances with prominent healthcare organizations, which enhances its reputation and provides access to a wider network.
  • Advanced technology platform: The company leverages cutting-edge technology to deliver innovative healthcare solutions, improving patient care and operational efficiency.
  • Skilled and experienced workforce: Evolent Health employs a talented team of professionals with extensive knowledge in healthcare management and technology, enabling them to deliver high-quality services.
  • Diversified service portfolio: The company offers a comprehensive range of services, including population health management, revenue cycle management, and clinical integration, catering to various needs within the healthcare industry.

Weaknesses

Although Evolent Health Inc has established itself as a prominent player in the healthcare industry, it also faces certain weaknesses that can hinder its growth and performance. These weaknesses include:

  • Dependence on key partners: Evolent Health heavily relies on its strategic partners, which could result in vulnerability if these partnerships were to weaken or dissolve.
  • Limited geographic presence: The company's operations are primarily focused on specific regions, which restricts its market reach and potential for expansion.
  • Highly regulated industry: The healthcare sector is subject to stringent regulations and compliance requirements, increasing the complexity and potential risks for Evolent Health.

Opportunities

Evolent Health Inc can capitalize on various opportunities in the healthcare industry to further enhance its growth and market position. These opportunities include:

  • Increasing demand for value-based care: The shift towards value-based care models presents an opportunity for Evolent Health to provide its expertise in population health management and drive better outcomes for patients and providers.
  • Advancements in healthcare technology: The rapid advancements in technology, such as telehealth and artificial intelligence, open doors for Evolent Health to develop innovative solutions that improve healthcare delivery and efficiency.
  • Growing need for healthcare analytics: The increasing emphasis on data-driven decision making in healthcare creates an opportunity for Evolent Health to leverage its advanced analytics capabilities and offer valuable insights to clients.

Threats

Evolent Health Inc faces several threats that pose challenges to its growth and competitive position within the healthcare industry. These threats include:

  • Intense competition: The healthcare industry is highly competitive, with numerous players offering similar services, which puts pressure on Evolent Health to continually differentiate itself and maintain market share.
  • Changing healthcare policies: Frequent changes in healthcare policies and regulations can impact Evolent Health's operations and profitability, requiring the company to regularly adapt and comply with evolving standards.
  • Financial constraints: The cost of implementing and scaling advanced healthcare technology can be substantial, which poses financial risks and challenges for Evolent Health.

Evolent Health Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Evolent Health Employees
Details
Date
Evolent Health Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Evolent Health Segments

Evolent Health Revenue by Segment (1/6)

  • Max

Performance Suite
Specialty Technology and Services Suite
Administrative Services
Cases
Details
Date
Performance Suite
Services revenue
Clinical solutions
Specialty Technology and Services Suite
Administrative Services
Administrative solutions
Cases
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
1.21 B USD
0.00 USD
0.00 USD
296.37 M USD
296.24 M USD
0.00 USD
156.63 M USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Evolent Health Revenue by Segment (2/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Platform and operations services
Premiums
Transformation services
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD

Evolent Health Revenue by Segment (3/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Services Revenue
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD

Evolent Health Revenue by Segment (4/6)

  • Max

Performance Suite
Specialty Technology and Services Suite
Administrative Services
Cases
Details
Date
Performance Suite
Specialty Technology and Services Suite
Administrative Services
Cases
Premiums
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
1.80 B USD
338.31 M USD
238.04 M USD
176.52 M USD
0.00 USD
Jan 1, 2025
1.02 B USD
353.23 M USD
226.68 M USD
168.98 M USD
0.00 USD

Evolent Health Revenue by Segment (5/6)

  • 3 Years

  • Max

Evolent Health Services Segment
Reportable segment
Clinical Solutions
Evolent Health Services
Details
Date
Evolent Health Services Segment
Reportable segment
Clinical Solutions
Evolent Health Services
Jan 1, 2022
0.00 USD
0.00 USD
944.51 M USD
407.50 M USD
Jan 1, 2023
1.96 B USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
2.55 B USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
1.88 B USD
0.00 USD
0.00 USD

Evolent Health Revenue by Segment (6/6)

  • Max

Evolent Health Services Segment
Details
Date
Evolent Health Services Segment
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
2.55 B USD
Jan 1, 2025
1.88 B USD

Evolent Health Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Evolent Health historical P/E ratio, EBIT multiple, and P/S ratio

Evolent Health annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Evolent Health shares outstanding

The number of shares of Evolent Health was 114.21 M in 2025. This indicates how many shares Evolent Health is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
88.33 M Stocks
Jan 1, 2022
99.80 M Stocks
Jan 1, 2023
113.59 M Stocks
Jan 1, 2024
115.03 M Stocks
Jan 1, 2025
114.21 M Stocks
Jan 1, 2026 (e)
114.21 M Stocks
Jan 1, 2027 (e)
114.21 M Stocks
Jan 1, 2028 (e)
114.21 M Stocks

Current Evolent Health forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
90.00 % (18)
Hold
10.00 % (2)
Sell
0.00 % (0)
12M Price Target
8.67
Last Price
3.09
Currency
USD
12M Return Potential
180.58 %
LTM Return
0 %

Evolent Health Analyst Rating Actions

DateFirmActionRatingReliability
7/28/2026
TD Cowen
TD Cowen
MaintainedBuy60
7/23/2026
Citigroup
Citigroup
DowngradeBuyNeutral48
7/21/2026
Canaccord Genuity
Canaccord Genuity
MaintainedBuy59
6/30/2026
Truist Securities
Truist Securities
DowngradeBuyHold–
6/12/2026
Truist Securities
Truist Securities
MaintainedBuy–
5/15/2026
Citigroup
Citigroup
MaintainedBuy48
5/12/2026
Canaccord Genuity
Canaccord Genuity
MaintainedBuy59
5/7/2026
Needham
Needham
MaintainedBuy70
3/2/2026
Oppenheimer
Oppenheimer
MaintainedOutperform65
2/26/2026
UBS
UBS
MaintainedBuy51

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Evolent Health Earnings Calls

2025

Evolent Health Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/6/2026-0.02USD-603.98 MUSD-2026 Q2
5/7/2026-0.05USD-540.02 MUSD-2026 Q1
2/25/20260.06USD-473.39 MUSD-2025 Q4
8/7/20250.08USD-464.02 MUSD-2025 Q2
5/1/20240.18USD-561.18 MUSD-2024 Q1
2/20/20240.14USD-547.97 MUSD-2023 Q4
7/31/20230.14USD-410.50 MUSD-2023 Q2
5/2/20230.13USD-397.85 MUSD-2023 Q1
2/21/20230.16USD-380.10 MUSD-2022 Q4
11/2/20220.12USD-362.12 MUSD-2022 Q3

EESG©

Eulerpool ESG Scorecard© for the Evolent Health stock

44/100
14
Environment
41
Social
76
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees68
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Evolent Health shareholder structure

% Name
9.76714%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
9.34113%
Cadian Capital Management LP
Cadian Capital Management LP
6.94173%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
6.58934%
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC
5.75564%
Durable Capital Partners LP
Durable Capital Partners LP
5.70985%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
...

Evolent Health Beneficial Ownership Filings (SEC 13D/G)

Free Float
95.7%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
10.50%
Capital Research Global Investors **
Capital Research Global Investors **
SEC ↗
10.00%
JPMORGAN CHASE & CO13-2624428
JPMORGAN CHASE & CO13-2624428
SEC ↗
9.99%
Glenn W. Welling
Glenn W. Welling
SEC ↗
9.99%
Engaged Capital, LLC
Engaged Capital, LLC
SEC ↗
9.30%
Cadian Capital Management, LP
Cadian Capital Management, LP
SEC ↗
8.44%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
8.40%
Magellan Health, Inc
Magellan Health, Inc
SEC ↗
8.40%
Centene Corporation
Centene Corporation
SEC ↗
8.10%
Morgan Stanley
Morgan Stanley
SEC ↗
7.10%
Rajeev Shah
Rajeev Shah
SEC ↗

Evolent Health Executives and Management Board

17 members · avg. age 52 · 24 % women

SB

Mr. Seth Blackley (46)

Chief Executive Officer, Co-Founder, Director · since 2011

11.14 M USD

Management

DM

Mr. Daniel Mccarthy (40)

President

7.48 M USD
JJ

Mr. John Johnson (41)

Chief Financial Officer

4.81 M USD
ER

Ms. Emily Rafferty (42)

Chief Operating Officer

2.01 M USD
JW

Mr. Jonathan Weinberg (58)

General Counsel

1.97 M USD
AS

Mr. Aammaad Shams (41)

Chief Accounting Officer

634,883.00 USD
DL

Dr. David Lim

Chief Clinical Officer

–

Board of Directors

CS

Ms. Cheryl Scott (75)

Independent Director

382,750.00 USD
RG

Mr. Russell Glass (49)

Independent Director

318,750.00 USD
KK

Ms. Kim Keck (61)

Independent Director

290,250.00 USD
PG

Mr. Peter Grua (71)

Independent Director

285,250.00 USD
CB

Mr. Craig Barbarosh (57)

Independent Director

282,500.00 USD
RJ

Mr. Richard Jelinek (59)

Independent Chairman of the Board

265,250.00 USD

Evolent Health Supply Chain

Evolent Health Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
3 companies
#NameTrend
1
Anthem
Customer·Health Care Providers & Services·US
0.22
0.23
0.06
0.63
0.47
0.87
2
CVS Health
Customer·Health Care Providers & Services·US
-0.68
-0.39
0.26
-0.02
0.26
0.84
3
Humana
Customer·Health Care Providers & Services·US
0.22
0.23
0.26
0.61
0.18
0.41

Frequently asked questions about Evolent Health

Evolent Health Inc operates under a value-based care business model. This means that the company focuses on improving patient outcomes while reducing healthcare costs. Evolent Health works closely with healthcare providers to transition from a fee-for-service payment system to a more accountable care approach. By aligning financial incentives with patient outcomes, Evolent Health helps providers deliver better-quality care at a lower cost. This business model seeks to drive innovation and efficiency in the healthcare industry while promoting a patient-centric approach. Evolent Health Inc is committed to transforming healthcare delivery through their value-based care model.

Evolent Health Inc is primarily active in the healthcare industry.

The main competitors of Evolent Health Inc in the market include industry leaders such as Cerner Corporation, Athenahealth, Inc., and Allscripts Healthcare Solutions, Inc.

Evolent Health Inc. is a leading healthcare technology and services provider. Founded in 2011, the company revolutionizes the delivery of care by partnering with health systems and physician organizations. Evolent Health's goal is to help these organizations transition to value-based care models, enhancing patient outcomes while controlling costs. With its innovative solutions and data-driven insights, the company enables healthcare providers to improve clinical and financial performance. Evolent Health Inc. has proven expertise in population health management and offers a comprehensive suite of services, including patient engagement, analytics, and revenue cycle management, making it a trusted partner in the healthcare industry.

Evolent Health Inc has achieved several significant milestones since its inception. The company successfully completed its initial public offering (IPO) in June 2015, marking a major achievement for its growth and expansion. Evolent Health Inc has also established strategic partnerships with numerous leading healthcare providers and organizations, further enhancing its position in the market. With a focus on value-based care and population health management, the company has been recognized for its innovative solutions in improving patient outcomes and reducing healthcare costs. Evolent Health Inc continues to drive industry progress through its commitment to delivering high-quality healthcare services.

Evolent Health Inc primarily operates in the United States. With headquarters in Arlington, Virginia, the company focuses on providing healthcare solutions across the nation. Evolent Health Inc has established a strong presence in several states, delivering value-based care to health systems, health plans, and physicians. Through its innovative population health management approach, Evolent Health Inc aims to improve healthcare outcomes and enhance the overall patient experience. With its extensive network and partnerships, the company continues to positively impact the healthcare industry within the United States.

Evolent Health Inc represents values of collaboration, innovation, and patient-centric care. The company's corporate philosophy revolves around transforming the health care industry by empowering physicians, improving outcomes, and reducing costs. Evolent Health Inc places a strong emphasis on technology-driven solutions and data analytics to optimize care delivery. With a focus on value-based care models, the company aims to drive positive change in the healthcare ecosystem. Evolent Health Inc's commitment to quality, accountability, and transparency positions them as a leading player in the industry, dedicated to improving the health and well-being of individuals and communities.

Analysts currently set an average price target of 9.33 USD for the Evolent Health stock (median: 8.67 USD), implying +201.8 % versus the latest price. The consensus is based on 20 analyst ratings.

Evolent Health Analyst Price Targets 2026

20 analysts currently rate the Evolent Health stock: 18 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Evolent Health to generate revenue of 2.50 B USD and earnings per share of 0.18 USD.

Evolent Health Analyst Price Targets 2026

Converted at the current exchange rate, the Evolent Health share trades at 2.68 EUR (3.09 USD).

The Evolent Health share (EVH) is listed on 4 stock exchanges, including: NYSE (EVH), Frankfurt (9EH.F), München (9EH.MU), Düsseldorf (9EH.DU).

Evolent Health Inc is a leading American provider of health management and claims processing services. The company offers a comprehensive and integrated health management system tailored to the needs of healthcare organizations and their patients. Evolent Health has three business areas: health plan management, popular reference group management for hospitals and healthcare organizations, and population health solution research. The main products of Evolent Health include: 1. Health plan management: Evolent Health supports health plans in managing insurance benefits for their customers. The company offers automation applications to reduce manual administrative processes, effective approaches to cost reduction for customers, and improved quality of service delivery. 2. Reference group management for hospitals and healthcare organizations: Evolent Health offers comprehensive reference group management services to hospitals and healthcare organizations. The company supports the implementation of solutions to improve workflows and provides a particularly tailored range of services. 3. Population health solutions: Evolent Health operates in the areas of digital transformation, analytics, and workforce management, developing corresponding population health solutions. These solutions are tailored to the individual needs of individuals and groups and aim to improve health and well-being. Overall, Evolent Health uses modern technologies and advanced analytics and data management tools to create a holistic strategy for health systems and service providers. The company works closely with its clients and partner companies to develop customized solutions and implement goals in a timely and effective manner. Evolent Health emphasizes open and trusting collaboration. In summary, the business model of Evolent Health is very complex and innovative. The company specializes in efficient and cost-effective health plan administration, as well as population health solutions. Through its tailored solutions and dedicated collaboration with clients and partners, Evolent Health has established a leading role in the healthcare sector.

The expected revenue of Evolent Health is 2.50 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Evolent Health is 20.17 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Evolent Health is currently 17.50. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Evolent Health stock.

The price-to-sales ratio (P/S) of Evolent Health is currently 0.14. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Evolent Health stock.

The Eulerpool Quality Score for Evolent Health is 3/10.

The ISIN of Evolent Health is US30050B1017. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Evolent Health is A14UCN. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Evolent Health is EVH. The ticker symbol is used to trade Evolent Health shares on the stock exchange.

Evolent Health paid dividends every year for the past 0 years.

Evolent Health is assigned to the 'Health' sector.

The dividends of Evolent Health are distributed in USD.

All fundamentals and in-depth analysis of Evolent Health

Our stock analysis for Evolent Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evolent Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Evolent Health Stock
Evolent Health Revenue→
Evolent Health Stock
Evolent Health Net Income→
Evolent Health Stock
Evolent Health P/E→
Evolent Health Stock
Evolent Health P/S→
Evolent Health Stock
Evolent Health EBIT→
Evolent Health Stock
Evolent Health Dividend→
Evolent Health Stock
Evolent Health Directors Dealings→
Evolent Health Stock
Evolent Health Stocks→
Evolent Health Stock
Evolent Health Market capitalization→
Evolent Health Stock
Evolent Health Debt→
Evolent Health Stock
Evolent Health Liabilities→
Evolent Health Stock
Evolent Health Equity→
Evolent Health Stock
Evolent Health AAQS→
Evolent Health Stock
Evolent Health Employees→
Evolent Health Stock
Evolent Health ROE→
Evolent Health Stock
Evolent Health ROA→
Evolent Health Stock
Evolent Health ROCE→
Evolent Health Stock
Evolent Health News→
Evolent Health Stock
Evolent Health Analyst Price Targets→

Health Stocks

EvolusEvofem BiosciencesEvome Medical TechnologiesEVIOEvommuneEverest OrganicsEVOQ RemediesEverest MedicinesEvotecEver Supreme Bio Technology CoEvotec SE ADREver Fortune. AI CoAll Stocks A–Z →